Kanner RE - Search Results

1

The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group.

Tashkin DP, Altose MD, Bleecker ER, Connett JE, Kanner RE, Lee WW, Wise R. Tashkin DP, et al. Among authors: kanner re. Am Rev Respir Dis. 1992 Feb;145(2 Pt 1):301-10. doi: 10.1164/ajrccm/145.2_Pt_1.301. Am Rev Respir Dis. 1992. PMID: 1736734 Clinical Trial.

2

Selection of spirometric measurements in a clinical trial, the Lung Health Study.

Wise RA, Connett J, Kurnow K, Grill J, Johnson L, Kanner R, Enright P. Wise RA, et al. Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):675-81. doi: 10.1164/ajrccm.151.3.7881655. Am J Respir Crit Care Med. 1995. PMID: 7881655 Clinical Trial.

3

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial.

Tashkin D, Kanner R, Bailey W, Buist S, Anderson P, Nides M, Gonzales D, Dozier G, Patel MK, Jamerson B. Tashkin D, et al. Lancet. 2001 May 19;357(9268):1571-5. doi: 10.1016/s0140-6736(00)04724-3. Lancet. 2001. PMID: 11377644 Clinical Trial.

4

Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases.

Smith CB, Golden CA, Kanner RE, Renzetti AD Jr. Smith CB, et al. Among authors: kanner re. Am Rev Respir Dis. 1980 Feb;121(2):225-32. doi: 10.1164/arrd.1980.121.2.225. Am Rev Respir Dis. 1980. PMID: 6244766

5

American Thoracic Society. Medical Section of the American Lung Association. Pulmonary rehabilitation.

Hodgkin JE, Farrell MJ, Gibson SR, Kanner RE, Kass I, Lampton LM, Nield M, Petty TL. Hodgkin JE, et al. Among authors: kanner re. Am Rev Respir Dis. 1981 Nov;124(5):663-6. Am Rev Respir Dis. 1981. PMID: 7305126 No abstract available.

6

Acute effects of PM10 pollution on pulmonary function of smokers with mild to moderate chronic obstructive pulmonary disease.

Pope CA 3rd, Kanner RE. Pope CA 3rd, et al. Among authors: kanner re. Am Rev Respir Dis. 1993 Jun;147(6 Pt 1):1336-40. doi: 10.1164/ajrccm/147.6_Pt_1.1336. Am Rev Respir Dis. 1993. PMID: 8503541

7

Bronchodilator response in the lung health study over 11 yrs.

Anthonisen NR, Lindgren PG, Tashkin DP, Kanner RE, Scanlon PD, Connett JE; Lung Health Study Research Group. Anthonisen NR, et al. Among authors: kanner re. Eur Respir J. 2005 Jul;26(1):45-51. doi: 10.1183/09031936.05.00102604. Eur Respir J. 2005. PMID: 15994388

8

Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

Kanner RE, Anthonisen NR, Connett JE; Lung Health Study Research Group. Kanner RE, et al. Am J Respir Crit Care Med. 2001 Aug 1;164(3):358-64. doi: 10.1164/ajrccm.164.3.2010017. Am J Respir Crit Care Med. 2001. PMID: 11500333 Clinical Trial.

9

Early intervention in chronic obstructive pulmonary disease. A review of the Lung Health Study results.

Kanner RE. Kanner RE. Med Clin North Am. 1996 May;80(3):523-47. doi: 10.1016/s0025-7125(05)70452-1. Med Clin North Am. 1996. PMID: 8637302 Clinical Trial.

10

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA Jr, Enright PL, Kanner RE, O'Hara P, et al. Anthonisen NR, et al. Among authors: kanner re. JAMA. 1994 Nov 16;272(19):1497-505. JAMA. 1994. PMID: 7966841 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results